Astapova, O., Minor, B. M. N., & Hammes, S. R. (2019). Physiological and Pathological Androgen Actions in the Ovary. Endocrinology, 160(5), 1166-1174. https://doi.org/10.1210/en.2019-00101
Astapova O, Minor BMN, Hammes SR. Physiological and Pathological Androgen Actions in the Ovary. Endocrinology. 2019;160(5):1166-1174. doi:10.1210/en.2019-00101
Astapova, Olga, et al. "Physiological and Pathological Androgen Actions in the Ovary." Endocrinology, vol. 160, no. 5, 2019, pp. 1166-1174.
For EndNote, Zotero or Mendeley:
Open access
Free to read
No reuse license
Open Access
Free full text on PubMed Central (PMC6937455)
RRM Academy Synopsis
Both low and high androgen activity impair ovarian function
A 2019 review of mostly animal studies reports that ovaries need a balanced level of androgen activity to grow follicles and ovulate. Early follicle growth depends on androgen signaling in granulosa cells. In a PCOS-like mouse model, androgen action in theca cells was needed, at least in part, for the reproductive harm.
Key Findings
Female mice lacking the androgen receptor in every tissue had up to 70% lower fecundity than littermates, from early loss of follicles and early cessation of fertility.
Mice lacking the receptor only in granulosa cells produced one-quarter the number of offspring of wild-type controls by 8 to 9 weeks of age, and about 10% by 24 to 25 weeks.
Deleting the receptor only in oocytes had no effect on fertility or fecundity in mice.
Prenatally androgenized mice were completely acyclic and infertile. Mice lacking the receptor only in theca cells, given the same treatment, kept some cyclicity and produced approximately half the offspring of untreated controls.
The review states that empirical evidence suggests little if any benefit of DHEA for fertility treatment success in women with diminished ovarian reserve, and no evidence of harm.
Interpretation
The paper is a narrative mini-review by endocrinologists at the University of Rochester. Most evidence comes from mice, rats, sheep and monkeys, where researchers removed the androgen receptor or exposed fetuses to extra androgen. These findings describe ovarian biology in animal models. Human data come from case-control studies of androgen receptor gene variants in women with PCOS, which gave mixed results, and from small DHEA studies in women with diminished ovarian reserve. The authors state that the cause of PCOS is still debated.
RRM Context
Ovulation depends on early follicle growth, and androgen signals in granulosa cells help drive it. Restorative reproductive medicine asks why follicles stall. In PCOS (also called PMOS, Polyendocrine Metabolic Ovarian Syndrome), too much androgen is one root cause under study.
Our editorial summary of this paper, not the article's abstract.
Abstract
Androgens, although traditionally thought to be male sex steroids, play important roles in female reproduction, both in healthy and pathological states. This mini-review focuses on recent advances in our knowledge of the role of androgens in the ovary. Androgen receptor (AR) is expressed in oocytes, granulosa cells, and theca cells, and is temporally regulated during follicular development. Mouse knockout studies have shown that AR expression in granulosa cells is critical for normal follicular development and subsequent ovulation. In addition, androgens are involved in regulating dynamic changes in ovarian steroidogenesis that are critical for normal cycling. Androgen effects on follicle development have been incorporated into clinical practice in women with diminished ovarian reserve, albeit with limited success in available literature. At the other extreme, androgen excess leads to disordered follicle development and anovulatory infertility known as polycystic ovary syndrome (PCOS), with studies suggesting that theca cell AR may mediate many of these negative effects. Finally, both prenatal and postnatal animal models of androgen excess have been developed and are being used to study the pathophysiology of PCOS both within the ovary and with regard to overall metabolic health. Taken together, current scientific consensus is that a careful balance of androgen activity in the ovary is necessary for reproductive health in women.
PMOS / PCOS has four diagnostic phenotypes and distinct metabolic, reproductive, and mental health implications. How RRM-trained clinicians approach diagnosis and treatment differently.